pharma · Solid Tumor, Adult · Solid Tumor · CTMX
CytomX Therapeutics
CytomX Therapeutics is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker CTMX. Primary therapeutic focus areas include Solid Tumor, Adult, Solid Tumor, Neoplasms, Solid Tumor
South San Francisco, USA HQ
98 Employees
Public company Type
CTMX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Employees
- 98
- Programs
- 8
- Drugs
- 0
- Patents
- 62
CX-072
Phase 2 · small molecule · Solid Tumor
CX-072 for Solid Tumor is a Phase 2 program (small_molecule) at CytomX Therapeutics with 2 ClinicalTrials.gov record(s).
Internal code CTMX-M-072-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CytomX Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Solid Tumor
- Status
- terminated
- Trials
- 2